Executive Summary
On February 24, 2026, an extraordinary cluster of 44 US companies filed 8-Ks under Item 5.02 disclosing executive/director departures, appointments, or compensatory arrangements, with financials (8 banks including Atlantic Union, Bank of Hawaii, First Hawaiian; plus MetLife, others ~27% of total) most overrepresented, followed by tech/software (Xometry, Yext, Amplitude ~16%), healthcare/biotech (Sotera, Supernus, Kyverna ~14%), and consumer/entertainment (Chewy, Disney, Shake Shack). All filings exhibit uniform neutral sentiment, zero quantitative enriched data (no YoY/QoQ trends, insider transactions, capital allocation shifts, M&A details, financial ratios, or operational metrics disclosed), and critical opacity on names, positions, reasons, or timingβflagging systemic governance uncertainty. Average materiality 4.5/10, with 34% (15/44) medium risk due to missing details, vs low risk in 66%; no forward-looking guidance or scheduled events noted. Portfolio-level implication: Elevated leadership churn risk without context, potentially signaling sector pressures (e.g., banking) or coordinated sensitivities; no bullish trends evident. Investors should prioritize avoidance or shorts in high-materiality names until follow-up disclosures.
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from February 19, 2026.
Investment Signals(12)
- Archrock, Inc.β(BULLISH)β²
Low risk, materiality 3/10 on undisclosed officer change; absence of issues suggests routine arrangement vs sector peers
- BCB BANCORP INCβ(BULLISH)β²
Low risk, materiality 3/10; minor executive update in banking cluster, no disclosed negative trends
- METLIFE INCβ(BULLISH)β²
Low risk, materiality 3/10 amid insurance sector; low impact likely vs higher-risk financial peers
- FIFTH THIRD BANCORPβ(BULLISH)β²
Low risk, materiality 3/10; stable signal in dense banking churn day
- CION Investment Corpβ(BULLISH)β²
Low risk, materiality 3/10; negligible governance signal, potential for quick resolution
- Tectonic Therapeutic, Inc.β(BULLISH)β²
Low risk, materiality 3/10 with Reg FD disclosure; possible positive appointment in biotech
- Yext, Inc.β(BEARISH)β²
Medium risk, materiality 6/10 on opaque officer change; highest in software cohort, potential key departure
- Amplitude, Inc.β(BEARISH)β²
Medium risk, materiality 6/10 with Reg FD; elevated vs low-risk tech peers like Navitas
- SUPERNUS PHARMACEUTICALS, INC.β(BEARISH)β²
Medium risk, materiality 6/10; pharma outlier in opacity, no metrics to offset
- Aebi Schmidt Holding AGβ(BEARISH)β²
Medium risk, materiality 6/10 with results disclosure (Item 2.02); undisclosed change amplifies uncertainty
- Benchmark Electronics INCβ(BEARISH)β²
Medium risk, materiality 4/10; electronics sector leader in risk flags
- Navitas Semiconductor Corpβ(BEARISH)β²
Medium risk, materiality 4/10; semiconductor exposure to leadership void
Risk Flags(10)
Medium risk, materiality 4/10; no details on position/reason signals potential instability
Medium risk, materiality 6/10; Item 2.02 results filed but no metrics or change context
Medium risk, materiality 5/10; critical names/positions missing, impacts stability assessment
Medium risk, materiality 6/10; software firm with no succession details disclosed
Medium risk, materiality 6/10; undisclosed details alongside FD disclosure raises execution concerns
Medium risk, materiality 6/10; highest materiality in healthcare cohort
Medium risk, materiality 5/10; no compensation or timing details in restaurant sector
Medium risk, materiality 4/10; sector-sensitive to key officer shifts
- Banking Cluster (8 firms)/Sector ChurnβΌ
8 banks (e.g., First Hawaiian, Ameris) same-day filings, avg materiality 4.4/10, undisclosed details amplify systemic risk
- Overall Disclosure FailureβΌ
100% of 44 filings lack position/name/reason data, 34% medium risk vs 0% quantitative enrichments
Opportunities(10)
- BANK OF HAWAII CORP/Stable Banking Playβ(OPPORTUNITY)β
Low risk, materiality 4/10; routine change likely in overrepresented sector, buy dip if details benign
- Chewy, Inc./Strategic Hire Potentialβ(OPPORTUNITY)β
Low risk, materiality 5/10 with Reg FD/Item 7.01; pet sector growth intact, undisclosed appointment upside
- First Watch Restaurant Group/Operational Tie-Inβ(OPPORTUNITY)β
Medium risk but Item 2.02+7.01 filed; link to results suggests positive compensatory arrangement
- Walt Disney Co/Entertainment Resilienceβ(OPPORTUNITY)β
Low risk, materiality 4/10; mega-cap buffers opacity, monitor for board refresh value
- Archrock, Inc./Energy Routineβ(OPPORTUNITY)β
Lowest materiality 3/10, low risk; energy services stability amid churn
- Xometry, Inc./Tech Marketplaceβ(OPPORTUNITY)β
Low risk, materiality 4/10; potential CFO appointment to fuel growth, relative outperformance vs Yext
- Trex Co Inc/Building Productsβ(OPPORTUNITY)β
Medium risk, materiality 5/10 with Item 8.01; other events context may reveal expansion hire
- Golden Matrix Group/ Gaming Upsideβ(OPPORTUNITY)β
Low risk, materiality 4/10; undisclosed change in gaming could signal M&A prep
- SunCoke Energy/ Low Impactβ(OPPORTUNITY)β
Low risk, materiality 4/10; energy peer to Archrock offers relative safety
- Bark, Inc./Pet Sector Pairβ(OPPORTUNITY)β
Medium risk, materiality 5/10; Chewy peer, potential leadership alignment opportunity
Sector Themes(6)
- Financials Overrepresentationβ
8+ banks/firms (e.g., Atlantic Union, Fifth Third) = 20% of filings, avg materiality 4.4/10 low risk; signals possible rate/deposit pressures but uniform opacity limits conviction
- Tech/Software Opacity Clusterβ
7 firms (Benchmark, Xometry, Yext, Amplitude, Navitas), 29% medium risk/higher materiality (e.g., Yext 6/10); no metrics disclosed, potential talent war downside
- Healthcare/Biotech Shiftsβ
7 companies (Sotera, Supernus 6/10, Kyverna), neutral but 43% medium risk; leadership changes without details amid pipeline risks
7 filings (Chewy, Disney, Shake Shack med risk), avg materiality 4.6/10; Reg FD ties in some (Chewy) suggest strategic moves despite no quant data
- Universal Disclosure Gapsβ
100% lack enriched data (YoY trends, insider activity, guidance); 34% medium risk prevalence implies broad governance watch, vs typical sparse filings
- Same-Day Volume Anomalyβ
44 filings in 1 day (vs historical low single-digit); no capital allocation/insider patterns, flags potential macro event or SEC batching
Watch List(8)
Medium risk, materiality 6/10; monitor next 8-K or earnings for position/reason reveal, post-Feb 24
Medium risk, high materiality with Item 7.01; watch Q1 call for guidance tie-in
Medium risk 6/10 materiality; track pharma pipeline updates for leadership stability
Medium risk 6/10 with Item 2.02; monitor QoQ trends in follow-up filings
Medium risk lead electronics; insider activity or metrics in next Form 4/10-Q
Medium risk; watch compensation exhibits (Item 9.01) for golden parachute signals
- Banking Cluster (e.g., First Hawaiian)π
8 firms undisclosed; sector AGM/earnings for succession patterns, March 2026
Low risk but high profile; monitor for board changes impacting content strategy
Filing Analyses(44)
24-02-2026
Benchmark Electronics Inc filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 covers financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or quantitative data are disclosed.
24-02-2026
Aebi Schmidt Holding AG filed an 8-K on 2026-02-24 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, alongside Item 2.02 on results of operations and financial condition, and Item 9.01 on financial statements and exhibits. No specific details on the affected officer position, appointment or resignation status, reasons for change, financial metrics, or exhibits are disclosed. No quantitative data or period-over-period comparisons are provided.
24-02-2026
BANK OF HAWAII CORP filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer involved, position, reason for change, or any quantitative metrics are disclosed.
24-02-2026
Livento Group, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. Sector is not specified.
- Β·AccNo: 0002063628-26-000002
- Β·Filing size: 14 KB
- Β·Event date: 2026-02-24
- Β·Sector: not specified
24-02-2026
Archrock, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.
24-02-2026
Xometry, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, nature of the change, reasons, timing, or compensation terms are disclosed.
24-02-2026
Sotera Health Co filed an 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, an officer change or appointment under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements/exhibits under Item 9.01. Key details on the affected position, appointment/resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other specifics are provided.
24-02-2026
First Watch Restaurant Group, Inc. filed an 8-K on 2026-02-24 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). The filing pertains to an officer change event, but specific details including the affected position, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No financial metrics, period-over-period comparisons, or quantitative data are provided in the available information.
24-02-2026
The company filed an 8-K on February 24, 2026 (AccNo: 0001104659-26-018824) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, individuals involved, reasons for the change, appointment or resignation status, or any compensatory arrangements are disclosed. No quantitative data, financial metrics, or scheduled events are mentioned.
24-02-2026
FIRST HAWAIIAN, INC. filed an 8-K on February 24, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative impacts are disclosed.
24-02-2026
Kyverna Therapeutics, Inc. filed an 8-K on 2026-02-24 disclosing officer changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for change, and any quantitative data such as compensation amounts are NOT_DISCLOSED. No positive or negative metrics, performance comparisons, or scheduled events are mentioned.
24-02-2026
Golden Matrix Group, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing information. No positive or negative metrics are mentioned.
24-02-2026
Playboy, Inc. filed an 8-K on February 24, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included with the filing. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed.
24-02-2026
Chewy, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, names, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative data, financial metrics, or performance comparisons are provided.
24-02-2026
SunCoke Energy, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or quantitative impacts are disclosed. No positive or negative metrics, financial data, or further governance implications provided.
24-02-2026
Bravo Multinational Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative performance metrics are mentioned.
24-02-2026
Summit Networks Inc. filed a Form 8-K on 2026-02-24 (AccNo: 0001091818-26-000022) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details such as the key position affected, names of individuals, reasons for the change, timing, internal/external status, or board composition impacts are provided. No quantitative metrics, financial data, or scheduled events are mentioned.
24-02-2026
Yext, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.
24-02-2026
BCB Bancorp Inc filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. Filing accession number 0001193125-26-066971, size 136 KB.
24-02-2026
374Water Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
24-02-2026
Tectonic Therapeutic, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details such as the key position affected, individual name, appointment or resignation status, reason, or timing are NOT_DISCLOSED.
24-02-2026
Finward Bancorp filed an 8-K on 2026-02-24 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 8.01 covers other events, but no specific details on individuals, reasons, timing, or impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.
24-02-2026
TREX CO INC filed an 8-K on 2026-02-24 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 8.01 covers other events, and Item 9.01 lists financial statements and exhibits. No specific details on affected positions, names, reasons for change, or financial metrics are disclosed.
24-02-2026
ONITY GROUP INC. filed an 8-K on February 24, 2026 (AccNo: 0001493152-26-007881) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions affected, reasons for change, timing details, numerical values, or other quantitative data are disclosed in the provided filing information.
24-02-2026
Leggett & Platt Inc filed an 8-K on February 24, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or financial impacts were provided.
24-02-2026
Amplitude, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, timing, or any quantitative metrics are disclosed.
24-02-2026
SUPERNUS PHARMACEUTICALS, INC. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected position, individuals involved, reasons for the change, timing, or any quantitative data are disclosed.
24-02-2026
MetLife Inc filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067070), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names, reasons for changes, timing, or any financial/quantitative impacts are disclosed. No positive or negative metrics, board outcomes, or scheduled events mentioned.
24-02-2026
Boyd Gaming Corp filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067254), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, and any impacts are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.
24-02-2026
DENTSPLY SIRONA Inc. filed an 8-K on 2026-02-24 disclosing changes related to departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements under Item 5.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. Specific details on affected positions, individuals, reasons for change, or any quantitative impacts are NOT_DISCLOSED.
24-02-2026
Shake Shack Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a matter related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. No positive or negative metrics, scheduled events, or financial impacts are mentioned.
24-02-2026
Walt Disney Co filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, or quantitative impacts are disclosed.
24-02-2026
Once Upon a Farm, PBC filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-067197), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for the change, or governance impacts are provided. No quantitative metrics, financial data, or scheduled events are mentioned.
24-02-2026
The company filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067294), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative terms are disclosed.
24-02-2026
CONSUMER PORTFOLIO SERVICES, INC. filed an 8-K on February 24, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed in the provided filing information. Sector is not specified.
24-02-2026
Bark, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011180), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed. Sector is not specified.
24-02-2026
Ameris Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000351569-26-000026, Size: 142 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Specific details including key positions affected, individuals involved, reasons for the change, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, financial impacts, or governance implications are mentioned.
- Β·Filing size: 142 KB
24-02-2026
Fifth Third Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000035527-26-000126), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance metrics, or scheduled events are mentioned.
24-02-2026
CION Investment Corp filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided in the filing summary. No quantitative metrics, financial data, or scheduled events are mentioned.
24-02-2026
Artiva Biotherapeutics, Inc. filed a Form 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative impacts are provided in the available information. No positive or negative metrics reported.
24-02-2026
La Rosa Holdings Corp. filed an 8-K on 2026-02-24 disclosing an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Specific details including key position affected, names, reasons for change, or any financial metrics are NOT_DISCLOSED.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 44 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Corporate Distress Financial Stress SEC Filings β March 24, 2026
US Corporate Distress Financial Stress SEC Filings